nodes	percent_of_prediction	percent_of_DWPC	metapath
Galantamine—CHRFAM7A—schizophrenia	0.183	0.255	CbGaD
Galantamine—CHRNB2—schizophrenia	0.179	0.25	CbGaD
Galantamine—CHRNA3—schizophrenia	0.136	0.189	CbGaD
Galantamine—CHRNA7—schizophrenia	0.105	0.147	CbGaD
Galantamine—CHRNA4—schizophrenia	0.0839	0.117	CbGaD
Galantamine—CYP2D6—schizophrenia	0.0299	0.0417	CbGaD
Galantamine—CHRNB3—pons—schizophrenia	0.00886	0.117	CbGeAlD
Galantamine—CHRNA10—ear—schizophrenia	0.00487	0.0644	CbGeAlD
Galantamine—CHRNA4—autonomic nervous system—schizophrenia	0.00245	0.0324	CbGeAlD
Galantamine—CHRNA4—telencephalic ventricle—schizophrenia	0.00218	0.0289	CbGeAlD
Galantamine—CHRNE—blood—schizophrenia	0.002	0.0265	CbGeAlD
Galantamine—CHRNB3—forebrain—schizophrenia	0.0019	0.0252	CbGeAlD
Galantamine—CHRNB3—telencephalon—schizophrenia	0.00175	0.0232	CbGeAlD
Galantamine—CHRNA6—forebrain—schizophrenia	0.00159	0.021	CbGeAlD
Galantamine—CHRNA6—telencephalon—schizophrenia	0.00146	0.0193	CbGeAlD
Galantamine—CHRNB3—midbrain—schizophrenia	0.00126	0.0166	CbGeAlD
Galantamine—CHRNA5—nervous system—schizophrenia	0.00114	0.0151	CbGeAlD
Galantamine—CHRNA5—central nervous system—schizophrenia	0.0011	0.0145	CbGeAlD
Galantamine—CHRNA6—midbrain—schizophrenia	0.00105	0.0139	CbGeAlD
Galantamine—CHRNB3—nervous system—schizophrenia	0.00103	0.0137	CbGeAlD
Galantamine—CHRNG—blood—schizophrenia	0.001	0.0132	CbGeAlD
Galantamine—CHRNB3—central nervous system—schizophrenia	0.000995	0.0132	CbGeAlD
Galantamine—CHRNG—midbrain—schizophrenia	0.000989	0.0131	CbGeAlD
Galantamine—CHRNB3—cerebellum—schizophrenia	0.000973	0.0129	CbGeAlD
Galantamine—CHRNB2—forebrain—schizophrenia	0.000913	0.0121	CbGeAlD
Galantamine—CHRNA3—forebrain—schizophrenia	0.000885	0.0117	CbGeAlD
Galantamine—CHRNA5—brain—schizophrenia	0.00087	0.0115	CbGeAlD
Galantamine—CHRNA6—nervous system—schizophrenia	0.000863	0.0114	CbGeAlD
Galantamine—CHRNA10—blood—schizophrenia	0.000849	0.0112	CbGeAlD
Galantamine—CHRNB2—telencephalon—schizophrenia	0.000839	0.0111	CbGeAlD
Galantamine—CHRNA6—central nervous system—schizophrenia	0.00083	0.011	CbGeAlD
Galantamine—CHRNA2—forebrain—schizophrenia	0.000823	0.0109	CbGeAlD
Galantamine—CHRNA6—cerebellum—schizophrenia	0.000812	0.0107	CbGeAlD
Galantamine—CHRNB3—brain—schizophrenia	0.00079	0.0105	CbGeAlD
Galantamine—CHRNB4—nervous system—schizophrenia	0.000783	0.0104	CbGeAlD
Galantamine—CYP3A4—urine—schizophrenia	0.000768	0.0102	CbGeAlD
Galantamine—CYP2D6—urine—schizophrenia	0.000756	0.01	CbGeAlD
Galantamine—CHRNB4—central nervous system—schizophrenia	0.000754	0.00998	CbGeAlD
Galantamine—CHRFAM7A—forebrain—schizophrenia	0.000716	0.00947	CbGeAlD
Galantamine—CHRNA6—brain—schizophrenia	0.000659	0.00872	CbGeAlD
Galantamine—CHRFAM7A—telencephalon—schizophrenia	0.000658	0.00871	CbGeAlD
Galantamine—ACHE—telencephalon—schizophrenia	0.00061	0.00808	CbGeAlD
Galantamine—CHRNB2—blood—schizophrenia	0.00061	0.00807	CbGeAlD
Galantamine—CHRNB2—midbrain—schizophrenia	0.000603	0.00797	CbGeAlD
Galantamine—CHRNB4—brain—schizophrenia	0.000599	0.00792	CbGeAlD
Galantamine—BCHE—blood plasma—schizophrenia	0.000596	0.00788	CbGeAlD
Galantamine—CHRNA7—forebrain—schizophrenia	0.000578	0.00765	CbGeAlD
Galantamine—CHRNA1—endocrine gland—schizophrenia	0.000575	0.00761	CbGeAlD
Galantamine—CHRNA4—forebrain—schizophrenia	0.00057	0.00754	CbGeAlD
Galantamine—CHRNA2—blood—schizophrenia	0.00055	0.00728	CbGeAlD
Galantamine—CHRNA7—telencephalon—schizophrenia	0.000532	0.00703	CbGeAlD
Galantamine—CHRNA4—telencephalon—schizophrenia	0.000524	0.00694	CbGeAlD
Galantamine—CHRNA3—endocrine gland—schizophrenia	0.000513	0.00679	CbGeAlD
Galantamine—CHRNB1—blood—schizophrenia	0.000512	0.00677	CbGeAlD
Galantamine—CHRNB1—midbrain—schizophrenia	0.000506	0.00669	CbGeAlD
Galantamine—CHRNB2—nervous system—schizophrenia	0.000495	0.00655	CbGeAlD
Galantamine—CHRNA3—nervous system—schizophrenia	0.00048	0.00636	CbGeAlD
Galantamine—CHRFAM7A—blood—schizophrenia	0.000479	0.00633	CbGeAlD
Galantamine—CHRNA2—endocrine gland—schizophrenia	0.000477	0.00631	CbGeAlD
Galantamine—CHRNB2—central nervous system—schizophrenia	0.000477	0.00631	CbGeAlD
Galantamine—CHRNB2—cerebellum—schizophrenia	0.000466	0.00617	CbGeAlD
Galantamine—CHRNA3—central nervous system—schizophrenia	0.000463	0.00612	CbGeAlD
Galantamine—CHRNA3—cerebellum—schizophrenia	0.000452	0.00598	CbGeAlD
Galantamine—CHRNA2—nervous system—schizophrenia	0.000447	0.00591	CbGeAlD
Galantamine—ACHE—midbrain—schizophrenia	0.000438	0.0058	CbGeAlD
Galantamine—CHRNA2—central nervous system—schizophrenia	0.00043	0.00569	CbGeAlD
Galantamine—CHRNA2—cerebellum—schizophrenia	0.00042	0.00556	CbGeAlD
Galantamine—CHRFAM7A—endocrine gland—schizophrenia	0.000415	0.00549	CbGeAlD
Galantamine—CHRNA1—brain—schizophrenia	0.000411	0.00544	CbGeAlD
Galantamine—CYP3A4—blood plasma—schizophrenia	0.000401	0.0053	CbGeAlD
Galantamine—CYP2D6—blood plasma—schizophrenia	0.000395	0.00522	CbGeAlD
Galantamine—CHRNB1—cerebellum—schizophrenia	0.000391	0.00517	CbGeAlD
Galantamine—CHRFAM7A—nervous system—schizophrenia	0.000389	0.00514	CbGeAlD
Galantamine—CHRNA7—blood—schizophrenia	0.000387	0.00511	CbGeAlD
Galantamine—Dihydrocodeine—CYP2D6—schizophrenia	0.000379	0.204	CrCbGaD
Galantamine—CHRNB2—brain—schizophrenia	0.000379	0.00501	CbGeAlD
Galantamine—CHRNA4—midbrain—schizophrenia	0.000377	0.00498	CbGeAlD
Galantamine—CHRFAM7A—central nervous system—schizophrenia	0.000374	0.00495	CbGeAlD
Galantamine—CHRNA3—brain—schizophrenia	0.000367	0.00486	CbGeAlD
Galantamine—CHRNA2—brain—schizophrenia	0.000341	0.00452	CbGeAlD
Galantamine—ACHE—cerebellum—schizophrenia	0.000339	0.00449	CbGeAlD
Galantamine—CHRNA7—endocrine gland—schizophrenia	0.000335	0.00444	CbGeAlD
Galantamine—CHRNA4—endocrine gland—schizophrenia	0.000331	0.00438	CbGeAlD
Galantamine—BCHE—forebrain—schizophrenia	0.000326	0.00432	CbGeAlD
Galantamine—Ethylmorphine—CYP2D6—schizophrenia	0.000318	0.171	CrCbGaD
Galantamine—CHRNB1—brain—schizophrenia	0.000318	0.0042	CbGeAlD
Galantamine—CHRNA7—nervous system—schizophrenia	0.000314	0.00415	CbGeAlD
Galantamine—CHRNA4—nervous system—schizophrenia	0.00031	0.0041	CbGeAlD
Galantamine—CHRNA7—central nervous system—schizophrenia	0.000302	0.004	CbGeAlD
Galantamine—BCHE—telencephalon—schizophrenia	0.0003	0.00397	CbGeAlD
Galantamine—CHRNA4—central nervous system—schizophrenia	0.000298	0.00394	CbGeAlD
Galantamine—CHRFAM7A—brain—schizophrenia	0.000297	0.00393	CbGeAlD
Galantamine—CHRNA4—cerebellum—schizophrenia	0.000291	0.00385	CbGeAlD
Galantamine—Hydrocodone—CYP2D6—schizophrenia	0.000291	0.157	CrCbGaD
Galantamine—ACHE—brain—schizophrenia	0.000275	0.00364	CbGeAlD
Galantamine—Oxycodone—CYP2D6—schizophrenia	0.000265	0.143	CrCbGaD
Galantamine—Codeine—CYP2D6—schizophrenia	0.000253	0.136	CrCbGaD
Galantamine—CHRNA7—brain—schizophrenia	0.00024	0.00317	CbGeAlD
Galantamine—CHRNA4—brain—schizophrenia	0.000237	0.00313	CbGeAlD
Galantamine—BCHE—blood—schizophrenia	0.000218	0.00289	CbGeAlD
Galantamine—CYP2D6—forebrain—schizophrenia	0.000216	0.00286	CbGeAlD
Galantamine—BCHE—midbrain—schizophrenia	0.000215	0.00285	CbGeAlD
Galantamine—Morphine—CYP2D6—schizophrenia	0.000205	0.11	CrCbGaD
Galantamine—CYP2D6—telencephalon—schizophrenia	0.000199	0.00263	CbGeAlD
Galantamine—BCHE—endocrine gland—schizophrenia	0.000189	0.0025	CbGeAlD
Galantamine—BCHE—nervous system—schizophrenia	0.000177	0.00234	CbGeAlD
Galantamine—BCHE—central nervous system—schizophrenia	0.000171	0.00226	CbGeAlD
Galantamine—BCHE—cerebellum—schizophrenia	0.000167	0.0022	CbGeAlD
Galantamine—CYP3A4—blood—schizophrenia	0.000147	0.00194	CbGeAlD
Galantamine—Morphine—ABCB1—schizophrenia	0.000146	0.0787	CrCbGaD
Galantamine—CYP2D6—blood—schizophrenia	0.000145	0.00191	CbGeAlD
Galantamine—BCHE—brain—schizophrenia	0.000135	0.00179	CbGeAlD
Galantamine—CYP3A4—endocrine gland—schizophrenia	0.000127	0.00169	CbGeAlD
Galantamine—CYP2D6—endocrine gland—schizophrenia	0.000125	0.00166	CbGeAlD
Galantamine—CYP3A4—nervous system—schizophrenia	0.000119	0.00158	CbGeAlD
Galantamine—CYP2D6—nervous system—schizophrenia	0.000117	0.00155	CbGeAlD
Galantamine—CYP3A4—central nervous system—schizophrenia	0.000115	0.00152	CbGeAlD
Galantamine—CYP2D6—central nervous system—schizophrenia	0.000113	0.00149	CbGeAlD
Galantamine—CYP2D6—cerebellum—schizophrenia	0.00011	0.00146	CbGeAlD
Galantamine—CYP2D6—brain—schizophrenia	8.97e-05	0.00119	CbGeAlD
Galantamine—CYP2D6—Metapathway biotransformation—CYP26B1—schizophrenia	1.42e-05	6.89e-05	CbGpPWpGaD
Galantamine—BCHE—Phospholipid metabolism—PLA2G4A—schizophrenia	1.4e-05	6.78e-05	CbGpPWpGaD
Galantamine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—schizophrenia	1.39e-05	6.76e-05	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—DLG4—schizophrenia	1.39e-05	6.73e-05	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—CHRNA4—schizophrenia	1.39e-05	6.71e-05	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—EP300—schizophrenia	1.37e-05	6.64e-05	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—COMT—schizophrenia	1.37e-05	6.63e-05	CbGpPWpGaD
Galantamine—CHRNB2—SIDS Susceptibility Pathways—TNF—schizophrenia	1.36e-05	6.6e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—CHRNB2—schizophrenia	1.36e-05	6.6e-05	CbGpPWpGaD
Galantamine—CHRNA4—Neuronal System—MAOA—schizophrenia	1.36e-05	6.58e-05	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—GRIN2B—schizophrenia	1.36e-05	6.57e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—NDST3—schizophrenia	1.36e-05	6.57e-05	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—SLC6A3—schizophrenia	1.34e-05	6.48e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIP4K2A—schizophrenia	1.33e-05	6.45e-05	CbGpPWpGaD
Galantamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—schizophrenia	1.33e-05	6.44e-05	CbGpPWpGaD
Galantamine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—schizophrenia	1.32e-05	6.42e-05	CbGpPWpGaD
Galantamine—CYP3A4—Tryptophan metabolism—CYP1A2—schizophrenia	1.32e-05	6.4e-05	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—EP300—schizophrenia	1.32e-05	6.4e-05	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—SNAP25—schizophrenia	1.29e-05	6.24e-05	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GCLM—schizophrenia	1.28e-05	6.22e-05	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—IL1B—schizophrenia	1.28e-05	6.21e-05	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—COMT—schizophrenia	1.27e-05	6.17e-05	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—HSPA8—schizophrenia	1.27e-05	6.16e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—schizophrenia	1.27e-05	6.14e-05	CbGpPWpGaD
Galantamine—ACHE—Transmission across Chemical Synapses—MAOA—schizophrenia	1.26e-05	6.13e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—ABCB1—schizophrenia	1.25e-05	6.04e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—CHRNA4—schizophrenia	1.24e-05	5.99e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PRODH—schizophrenia	1.23e-05	5.96e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—PLA2G4A—schizophrenia	1.21e-05	5.86e-05	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—DLG4—schizophrenia	1.19e-05	5.78e-05	CbGpPWpGaD
Galantamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—schizophrenia	1.18e-05	5.72e-05	CbGpPWpGaD
Galantamine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—schizophrenia	1.17e-05	5.65e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—MAN2A1—schizophrenia	1.17e-05	5.65e-05	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—GRIN2B—schizophrenia	1.16e-05	5.65e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—SNAP25—schizophrenia	1.15e-05	5.57e-05	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—SLC6A3—schizophrenia	1.15e-05	5.56e-05	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—EP300—schizophrenia	1.15e-05	5.55e-05	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—COMT—schizophrenia	1.14e-05	5.51e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—HSPA8—schizophrenia	1.13e-05	5.49e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PRKD1—schizophrenia	1.13e-05	5.48e-05	CbGpPWpGaD
Galantamine—BCHE—Transmission across Chemical Synapses—MAOA—schizophrenia	1.13e-05	5.47e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—DPP4—schizophrenia	1.12e-05	5.42e-05	CbGpPWpGaD
Galantamine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—schizophrenia	1.1e-05	5.34e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PRODH—schizophrenia	1.1e-05	5.32e-05	CbGpPWpGaD
Galantamine—CHRNB4—SIDS Susceptibility Pathways—TNF—schizophrenia	1.07e-05	5.19e-05	CbGpPWpGaD
Galantamine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—schizophrenia	1.07e-05	5.18e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—DLG4—schizophrenia	1.06e-05	5.15e-05	CbGpPWpGaD
Galantamine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—schizophrenia	1.05e-05	5.11e-05	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—IL1B—schizophrenia	1.05e-05	5.07e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—MAN2A1—schizophrenia	1.04e-05	5.04e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—GRIN2B—schizophrenia	1.04e-05	5.04e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—SLC6A3—schizophrenia	1.02e-05	4.96e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PRKD1—schizophrenia	1.01e-05	4.89e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—MPC2—schizophrenia	1e-05	4.86e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—DPP4—schizophrenia	9.97e-06	4.83e-05	CbGpPWpGaD
Galantamine—CHRNB2—Circadian rythm related genes—TP53—schizophrenia	9.8e-06	4.75e-05	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—COMT—schizophrenia	9.76e-06	4.73e-05	CbGpPWpGaD
Galantamine—ACHE—Neuronal System—MAOA—schizophrenia	9.69e-06	4.7e-05	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—schizophrenia	9.58e-06	4.64e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—ESR1—schizophrenia	9.5e-06	4.6e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP26B1—schizophrenia	9.42e-06	4.57e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	9.35e-06	4.53e-05	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—EP300—schizophrenia	9.34e-06	4.53e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PLCH2—schizophrenia	9.32e-06	4.52e-05	CbGpPWpGaD
Galantamine—CHRNA7—SIDS Susceptibility Pathways—TNF—schizophrenia	9.3e-06	4.51e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP26B1—schizophrenia	9.29e-06	4.5e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—MPC2—schizophrenia	8.94e-06	4.34e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NDST3—schizophrenia	8.76e-06	4.25e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—COMT—schizophrenia	8.71e-06	4.22e-05	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—schizophrenia	8.66e-06	4.2e-05	CbGpPWpGaD
Galantamine—BCHE—Neuronal System—MAOA—schizophrenia	8.65e-06	4.19e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GCLM—schizophrenia	8.4e-06	4.07e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	8.34e-06	4.04e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PLCH2—schizophrenia	8.32e-06	4.03e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SLC27A5—schizophrenia	8.31e-06	4.03e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ACSL6—schizophrenia	8.31e-06	4.03e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	8.12e-06	3.94e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—DAO—schizophrenia	7.93e-06	3.84e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NDST3—schizophrenia	7.82e-06	3.79e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PNP—schizophrenia	7.6e-06	3.68e-05	CbGpPWpGaD
Galantamine—CHRNA4—SIDS Susceptibility Pathways—TNF—schizophrenia	7.58e-06	3.68e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ACSL6—schizophrenia	7.41e-06	3.59e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SLC27A5—schizophrenia	7.41e-06	3.59e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	7.24e-06	3.51e-05	CbGpPWpGaD
Galantamine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—schizophrenia	7.21e-06	3.49e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—DAO—schizophrenia	7.07e-06	3.43e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—NDUFV2—schizophrenia	7.06e-06	3.42e-05	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—CYP1A2—schizophrenia	7.04e-06	3.41e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—CYP1A2—schizophrenia	6.94e-06	3.36e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PNP—schizophrenia	6.78e-06	3.29e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIP4K2A—schizophrenia	6.64e-06	3.22e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	6.59e-06	3.19e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—NDUFV2—schizophrenia	6.3e-06	3.05e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP26B1—schizophrenia	6.01e-06	2.91e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIP4K2A—schizophrenia	5.93e-06	2.87e-05	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—COMT—schizophrenia	5.9e-06	2.86e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	5.88e-06	2.85e-05	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GSTP1—schizophrenia	5.87e-06	2.84e-05	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—MAOA—schizophrenia	5.85e-06	2.84e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—COMT—schizophrenia	5.81e-06	2.82e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—GSTP1—schizophrenia	5.79e-06	2.8e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of proteins—ACE—schizophrenia	5.78e-06	2.8e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	5.67e-06	2.75e-05	CbGpPWpGaD
Galantamine—CYP2D6—Biological oxidations—GSTM1—schizophrenia	5.39e-06	2.61e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP26B1—schizophrenia	5.36e-06	2.6e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—TPH1—schizophrenia	5.35e-06	2.59e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GCLM—schizophrenia	5.35e-06	2.59e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metapathway biotransformation—GSTM1—schizophrenia	5.32e-06	2.58e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of proteins—ACE—schizophrenia	5.15e-06	2.5e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP2D6—schizophrenia	5.09e-06	2.47e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	5.05e-06	2.45e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PRODH—schizophrenia	5.04e-06	2.45e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PRKD1—schizophrenia	5.03e-06	2.44e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP2D6—schizophrenia	5.02e-06	2.43e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—TPH1—schizophrenia	4.78e-06	2.31e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GCLM—schizophrenia	4.78e-06	2.31e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	4.6e-06	2.23e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—CYP1A2—schizophrenia	4.6e-06	2.23e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—CYP1A2—schizophrenia	4.54e-06	2.2e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	4.5e-06	2.18e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PRKD1—schizophrenia	4.49e-06	2.18e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GAPDH—schizophrenia	4.2e-06	2.04e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CLOCK—schizophrenia	4.16e-06	2.02e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—APOE—schizophrenia	4.15e-06	2.01e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MPC2—schizophrenia	4.11e-06	1.99e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	4.11e-06	1.99e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—TPH2—schizophrenia	4.06e-06	1.97e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CACNB2—schizophrenia	4.06e-06	1.97e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	4.06e-06	1.97e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—DPYD—schizophrenia	3.99e-06	1.93e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—COMT—schizophrenia	3.85e-06	1.87e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTP1—schizophrenia	3.84e-06	1.86e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—MAOA—schizophrenia	3.83e-06	1.86e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PLCH2—schizophrenia	3.82e-06	1.85e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—COMT—schizophrenia	3.8e-06	1.84e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTP1—schizophrenia	3.78e-06	1.83e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GAPDH—schizophrenia	3.75e-06	1.82e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CLOCK—schizophrenia	3.71e-06	1.8e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CACNA1C—schizophrenia	3.71e-06	1.8e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—APOE—schizophrenia	3.71e-06	1.8e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	3.66e-06	1.78e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CACNB2—schizophrenia	3.62e-06	1.75e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—TPH2—schizophrenia	3.62e-06	1.75e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PIK3C2A—schizophrenia	3.62e-06	1.75e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NDST3—schizophrenia	3.59e-06	1.74e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—DPYD—schizophrenia	3.56e-06	1.73e-05	CbGpPWpGaD
Galantamine—CYP3A4—Biological oxidations—GSTM1—schizophrenia	3.53e-06	1.71e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metapathway biotransformation—GSTM1—schizophrenia	3.48e-06	1.69e-05	CbGpPWpGaD
Galantamine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	3.43e-06	1.66e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ACSL6—schizophrenia	3.41e-06	1.65e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SLC27A5—schizophrenia	3.41e-06	1.65e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CACNA1C—schizophrenia	3.31e-06	1.6e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PRODH—schizophrenia	3.3e-06	1.6e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—DAO—schizophrenia	3.25e-06	1.58e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—SNAP25—schizophrenia	3.24e-06	1.57e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP2D6—schizophrenia	3.24e-06	1.57e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PIK3C2A—schizophrenia	3.23e-06	1.56e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PNP—schizophrenia	3.12e-06	1.51e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—CYP1A2—schizophrenia	2.93e-06	1.42e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—NDUFV2—schizophrenia	2.9e-06	1.4e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP2D6—schizophrenia	2.89e-06	1.4e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—SNAP25—schizophrenia	2.89e-06	1.4e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—TH—schizophrenia	2.89e-06	1.4e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIP4K2A—schizophrenia	2.72e-06	1.32e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MPC2—schizophrenia	2.69e-06	1.3e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—CYP1A2—schizophrenia	2.62e-06	1.27e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—TH—schizophrenia	2.58e-06	1.25e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PLCH2—schizophrenia	2.5e-06	1.21e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP26B1—schizophrenia	2.46e-06	1.19e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—COMT—schizophrenia	2.46e-06	1.19e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTP1—schizophrenia	2.45e-06	1.19e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—MAOA—schizophrenia	2.44e-06	1.18e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism of lipids and lipoproteins—EP300—schizophrenia	2.37e-06	1.15e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NDST3—schizophrenia	2.35e-06	1.14e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—ABCB1—schizophrenia	2.32e-06	1.12e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—GSTM1—schizophrenia	2.25e-06	1.09e-05	CbGpPWpGaD
Galantamine—ACHE—Metabolism—PLA2G4A—schizophrenia	2.25e-06	1.09e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SLC27A5—schizophrenia	2.23e-06	1.08e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ACSL6—schizophrenia	2.23e-06	1.08e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GCLM—schizophrenia	2.2e-06	1.06e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TPH1—schizophrenia	2.2e-06	1.06e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—COMT—schizophrenia	2.19e-06	1.06e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTP1—schizophrenia	2.18e-06	1.06e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—MAOA—schizophrenia	2.18e-06	1.06e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—DAO—schizophrenia	2.13e-06	1.03e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism of lipids and lipoproteins—EP300—schizophrenia	2.11e-06	1.02e-05	CbGpPWpGaD
Galantamine—BCHE—Metabolism—ABCB1—schizophrenia	2.07e-06	1e-05	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PRKD1—schizophrenia	2.06e-06	1e-05	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PNP—schizophrenia	2.04e-06	9.88e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—PLA2G4A—schizophrenia	2.01e-06	9.72e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—GSTM1—schizophrenia	2.01e-06	9.72e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—MTHFR—schizophrenia	1.99e-06	9.63e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—NDUFV2—schizophrenia	1.89e-06	9.18e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—APOE—schizophrenia	1.85e-06	8.97e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—APOA1—schizophrenia	1.83e-06	8.86e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIP4K2A—schizophrenia	1.78e-06	8.63e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—MTHFR—schizophrenia	1.77e-06	8.59e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GAPDH—schizophrenia	1.72e-06	8.35e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CLOCK—schizophrenia	1.71e-06	8.28e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TPH2—schizophrenia	1.66e-06	8.07e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CACNB2—schizophrenia	1.66e-06	8.07e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—APOE—schizophrenia	1.65e-06	8e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—DPYD—schizophrenia	1.64e-06	7.94e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—APOA1—schizophrenia	1.63e-06	7.91e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP26B1—schizophrenia	1.61e-06	7.81e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CACNA1C—schizophrenia	1.52e-06	7.38e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PIK3C2A—schizophrenia	1.48e-06	7.19e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TPH1—schizophrenia	1.44e-06	6.96e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GCLM—schizophrenia	1.44e-06	6.96e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PRKD1—schizophrenia	1.35e-06	6.54e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—SNAP25—schizophrenia	1.33e-06	6.45e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—CYP1A2—schizophrenia	1.2e-06	5.83e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—TH—schizophrenia	1.19e-06	5.75e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GAPDH—schizophrenia	1.13e-06	5.46e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CLOCK—schizophrenia	1.12e-06	5.41e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CACNB2—schizophrenia	1.09e-06	5.27e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TPH2—schizophrenia	1.09e-06	5.27e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—DPYD—schizophrenia	1.07e-06	5.19e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—EP300—schizophrenia	1.05e-06	5.11e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—COMT—schizophrenia	1.01e-06	4.89e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTP1—schizophrenia	1e-06	4.86e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MAOA—schizophrenia	1e-06	4.85e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CACNA1C—schizophrenia	9.95e-07	4.82e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PIK3C2A—schizophrenia	9.7e-07	4.7e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—ABCB1—schizophrenia	9.5e-07	4.6e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—EP300—schizophrenia	9.4e-07	4.56e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—PLA2G4A—schizophrenia	9.22e-07	4.47e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—GSTM1—schizophrenia	9.22e-07	4.47e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—SNAP25—schizophrenia	8.7e-07	4.22e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP2D6—schizophrenia	8.7e-07	4.22e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—MTHFR—schizophrenia	8.15e-07	3.95e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—CYP1A2—schizophrenia	7.87e-07	3.81e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—TH—schizophrenia	7.75e-07	3.76e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—APOE—schizophrenia	7.59e-07	3.68e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—APOA1—schizophrenia	7.5e-07	3.64e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—COMT—schizophrenia	6.59e-07	3.2e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTP1—schizophrenia	6.56e-07	3.18e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MAOA—schizophrenia	6.55e-07	3.17e-06	CbGpPWpGaD
Galantamine—ACHE—Metabolism—AKT1—schizophrenia	6.37e-07	3.09e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—ABCB1—schizophrenia	6.21e-07	3.01e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—PLA2G4A—schizophrenia	6.03e-07	2.92e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—GSTM1—schizophrenia	6.03e-07	2.92e-06	CbGpPWpGaD
Galantamine—BCHE—Metabolism—AKT1—schizophrenia	5.68e-07	2.75e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—MTHFR—schizophrenia	5.33e-07	2.58e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—APOE—schizophrenia	4.96e-07	2.4e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—APOA1—schizophrenia	4.9e-07	2.38e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—EP300—schizophrenia	4.32e-07	2.1e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—EP300—schizophrenia	2.83e-07	1.37e-06	CbGpPWpGaD
Galantamine—CYP2D6—Metabolism—AKT1—schizophrenia	2.61e-07	1.27e-06	CbGpPWpGaD
Galantamine—CYP3A4—Metabolism—AKT1—schizophrenia	1.71e-07	8.28e-07	CbGpPWpGaD
